XNAS 02 Jan, 2026 4:30 PM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jon Congleton | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 24,082 | 0 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 21 Nov 2025 | 24,082 | 655,387 | - | 0.5 | 13,004 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 43.35 per share. | 20 Nov 2025 | 1,000,000 | 7,903,838 | - | 43.4 | 43,350,000 | Common Stock |
| Daphne Karydas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 13 Nov 2025 | 15,000 | 15,000 | - | 10.2 | 153,000 | Common Stock |
| Daphne Karydas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2025 | 15,000 | 17,900 | - | - | Stock Option | |
| Daphne Karydas | Director | Sale of securities on an exchange or to another person at price $ 46.36 per share. | 13 Nov 2025 | 4,885 | 0 | - | 46.4 | 226,446 | Common Stock |
| Daphne Karydas | Director | Sale of securities on an exchange or to another person at price $ 45.81 per share. | 13 Nov 2025 | 10,115 | 4,885 | - | 45.8 | 463,351 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 11 Nov 2025 | 4,000 | 805,637 | - | 43.5 | 173,984 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.31 per share. | 11 Nov 2025 | 8,862 | 809,637 | - | 42.3 | 374,947 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.64 per share. | 11 Nov 2025 | 12,806 | 818,499 | - | 41.6 | 533,235 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.89 per share. | 11 Nov 2025 | 32,850 | 631,305 | - | 46.9 | 1,540,212 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.83 per share. | 11 Nov 2025 | 112,275 | 664,155 | - | 45.8 | 5,145,956 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.20 per share. | 11 Nov 2025 | 29,207 | 776,430 | - | 45.2 | 1,320,165 | Common Stock |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.44 per share. | 11 Nov 2025 | 6,613 | 138,920 | - | 15.4 | 102,105 | Common Stock |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.25 per share. | 11 Nov 2025 | 44,079 | 132,307 | - | 14.3 | 628,126 | Common Stock |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 11 Nov 2025 | 34,414 | 88,228 | - | 16 | 550,624 | Common Stock |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 20,547 | 53,814 | - | 10.2 | 209,579 | Common Stock |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 6,613 | 4,888 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 44,079 | 91,592 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 20,547 | 135,674 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 34,414 | 20,662 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 46.88 per share. | 11 Nov 2025 | 32,718 | 19,396 | - | 46.9 | 1,533,977 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 45.93 per share. | 11 Nov 2025 | 38,900 | 52,114 | - | 45.9 | 1,786,588 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 45.18 per share. | 11 Nov 2025 | 8,456 | 91,014 | - | 45.2 | 382,046 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 11 Nov 2025 | 4,142 | 99,470 | - | 43.5 | 180,183 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.34 per share. | 11 Nov 2025 | 8,485 | 103,612 | - | 42.3 | 359,258 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 11 Nov 2025 | 12,952 | 112,097 | - | 41.7 | 539,479 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.68 per share. | 11 Nov 2025 | 1,561 | 125,049 | - | 42.7 | 66,623 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 41.87 per share. | 11 Nov 2025 | 11,295 | 126,610 | - | 41.9 | 472,932 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 11 Nov 2025 | 1,015 | 137,905 | - | 42 | 42,630 | Common Stock |
| Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 47.28 per share. | 11 Nov 2025 | 1,933 | 0 | - | 47.3 | 91,386 | Common Stock |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 10,000 | 34,000 | - | - | Stock Option | |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 2,742 | 8,225 | - | - | Stock Option | |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 6,933 | 10,967 | - | - | Stock Option | |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 15,000 | 17,900 | - | - | Stock Option | |
| Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 11 Nov 2025 | 12,742 | 0 | - | 46.5 | 592,503 | Common Stock |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.69 per share. | 11 Nov 2025 | 10,000 | 12,742 | - | 12.7 | 126,900 | Common Stock |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 2,742 | 2,742 | - | 10.2 | 27,968 | Common Stock |
| Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 11 Nov 2025 | 5,000 | 1,933 | - | 46.5 | 232,500 | Common Stock |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 6,933 | 6,933 | - | 10.2 | 70,717 | Common Stock |
| Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 47.08 per share. | 11 Nov 2025 | 5,000 | 0 | - | 47.1 | 235,408 | Common Stock |
| Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 42.43 per share. | 11 Nov 2025 | 10,000 | 5,000 | - | 42.4 | 424,298 | Common Stock |
| Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 15,000 | 15,000 | - | 10.2 | 153,000 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 43.01 per share. | 15 Oct 2025 | 10,369 | 71,155 | - | 43.0 | 445,982 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.63 per share. | 13 Oct 2025 | 13,548 | 832,857 | - | 42.6 | 577,544 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.03 per share. | 13 Oct 2025 | 1,552 | 831,305 | - | 43.0 | 66,782 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 42.26 per share. | 13 Oct 2025 | 3,392 | 116,865 | - | 42.3 | 143,333 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 41.90 per share. | 13 Oct 2025 | 7,366 | 120,257 | - | 41.9 | 308,651 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.47 per share. | 15 Sep 2025 | 2,065 | 81,524 | - | 36.5 | 75,320 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.90 per share. | 15 Sep 2025 | 9,302 | 83,589 | - | 35.9 | 333,946 | Common Stock |
| Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 25.50 per share. | 04 Sep 2025 | 588,235 | 588,235 | - | 25.5 | 14,999,993 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.93 per share. | 12 Aug 2025 | 11,365 | 92,891 | - | 12.9 | 146,987 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Aug 2025 | 6,349 | 104,256 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 6,349 | 82,531 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 28 Jul 2025 | 807 | 192,859 | - | 14.0 | 11,302 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 28 Jul 2025 | 8,425 | 132,934 | - | 15.1 | 127,203 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 28 Jul 2025 | 51,500 | 141,359 | - | 14.7 | 757,168 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.04 per share. | 28 Jul 2025 | 12,946 | 193,666 | - | 14.0 | 181,803 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 6,349 | 88,880 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.59 per share. | 14 Jul 2025 | 11,366 | 97,907 | - | 14.6 | 165,879 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 14 Jul 2025 | 6,349 | 109,273 | - | 1.1 | 6,857 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.51 per share. | 11 Jul 2025 | 15,884 | 846,405 | - | 14.5 | 230,431 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 14.45 per share. | 11 Jul 2025 | 10,758 | 206,612 | - | 14.5 | 155,454 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,348 | 95,229 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 12 Jun 2025 | 11,366 | 101,651 | - | 14.6 | 165,931 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Jun 2025 | 6,348 | 113,017 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.29 per share. | 14 May 2025 | 11,366 | 106,669 | - | 15.3 | 173,774 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 May 2025 | 6,349 | 118,035 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2025 | 6,349 | 101,577 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 6,348 | 107,926 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 14 Apr 2025 | 8,400 | 111,686 | - | 14.8 | 124,572 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 14 Apr 2025 | 2,966 | 120,086 | - | 13.7 | 40,613 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 14 Apr 2025 | 6,348 | 123,052 | - | 1.1 | 6,856 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.19 per share. | 11 Apr 2025 | 15,319 | 862,289 | - | 12.2 | 186,803 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 11 Apr 2025 | 10,757 | 215,340 | - | 12.1 | 129,684 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.77 per share. | 01 Apr 2025 | 22,406 | 116,704 | - | 16.8 | 375,749 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,606 | 114,274 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 01 Apr 2025 | 2,791 | 139,110 | - | 16.0 | 44,717 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 01 Apr 2025 | 30,574 | 141,901 | - | 15.0 | 458,543 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 01 Apr 2025 | 1,606 | 172,475 | - | 1.1 | 1,734 | Common Stock |
| Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 13 Mar 2025 | 600,000 | 5,674,916 | - | 13.5 | 8,100,000 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 13 Mar 2025 | 259,259 | 8,903,838 | - | 13.5 | 3,499,997 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 6,349 | 115,880 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Mar 2025 | 6,349 | 170,869 | - | 1.1 | 6,857 | Common Stock |
| Glenn P. Sblendorio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 570,000 | 570,000 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Daphne Karydas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 0 | - | - | Stock Option | |
| Alexander M. Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Feb 2025 | 6,348 | 164,520 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 6,348 | 122,229 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 13 Jan 2025 | 18,333 | 877,608 | - | 9.1 | 166,082 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 13 Jan 2025 | 5,018 | 151,823 | - | 0.5 | 2,710 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 13 Jan 2025 | 6,349 | 158,172 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 5,018 | 0 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 6,349 | 128,577 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 9.09 per share. | 13 Jan 2025 | 10,657 | 226,197 | - | 9.1 | 96,901 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 9.63 per share. | 13 Jan 2025 | 100 | 226,097 | - | 9.6 | 963 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 5,017 | 5,018 | - | - | Stock Option | |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Dec 2024 | 5,017 | 146,008 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Nov 2024 | 5,017 | 140,991 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 5,026 | 134,926 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 5,017 | 10,035 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 11 Nov 2024 | 5,026 | 140,991 | - | 15.0 | 75,398 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Nov 2024 | 5,026 | 146,017 | - | 1.1 | 5,428 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 06 Nov 2024 | 25,482 | 135,974 | - | 15.0 | 383,066 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 06 Nov 2024 | 25,482 | 161,456 | - | 1.1 | 27,521 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 25,482 | 139,952 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.52 per share. | 11 Oct 2024 | 15,271 | 895,941 | - | 13.5 | 206,433 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Oct 2024 | 5,017 | 130,622 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 5,352 | 165,434 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 5,017 | 15,052 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Oct 2024 | 5,352 | 135,974 | - | 1.1 | 5,780 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.57 per share. | 11 Oct 2024 | 10,757 | 236,854 | - | 13.6 | 146,004 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Sep 2024 | 5,018 | 119,256 | - | 0.5 | 2,710 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 6,349 | 170,786 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 5,018 | 20,069 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Sep 2024 | 6,349 | 125,605 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 6,348 | 177,135 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 5,017 | 25,087 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Aug 2024 | 6,348 | 114,238 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 12 Aug 2024 | 5,017 | 107,890 | - | 0.5 | 2,709 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 24 Jul 2024 | 550,000 | 8,644,579 | - | 13.1 | 7,177,500 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 525 | 183,483 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Jul 2024 | 525 | 102,873 | - | 15.0 | 7,876 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 16 Jul 2024 | 525 | 103,398 | - | 1.1 | 567 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 11 Jul 2024 | 15,746 | 911,212 | - | 13.3 | 210,075 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Jul 2024 | 6,349 | 102,873 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 6,349 | 184,008 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Jul 2024 | 5,017 | 96,524 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 5,017 | 30,104 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.14 per share. | 11 Jul 2024 | 10,757 | 247,611 | - | 13.1 | 141,394 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 17 Jun 2024 | 17,766 | 958,505 | - | 12.3 | 217,712 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.99 per share. | 17 Jun 2024 | 16,607 | 941,898 | - | 12.0 | 199,073 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.73 per share. | 17 Jun 2024 | 14,940 | 926,958 | - | 11.7 | 175,237 | Common Stock |
| Alexander M. Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 12 Jun 2024 | 16,607 | 1,032,461 | - | 12.8 | 212,013 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 12 Jun 2024 | 16,229 | 976,271 | - | 12.5 | 203,163 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.74 per share. | 12 Jun 2024 | 39,961 | 992,500 | - | 12.7 | 509,027 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 5,017 | 35,121 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Jun 2024 | 6,349 | 89,729 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Jun 2024 | 5,017 | 83,380 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 6,349 | 190,357 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 11 Jun 2024 | 96,815 | 255,462 | - | 12.9 | 1,252,718 | Common Stock |
| Glenn P. Sblendorio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Daphne Karydas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Olivier Litzka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 May 2024 | 22,000 | 0 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 13 May 2024 | 6,348 | 78,363 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 6,348 | 196,706 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 5,018 | 40,138 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 13 May 2024 | 5,018 | 72,015 | - | 0.5 | 2,710 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 09 May 2024 | 100 | 67,097 | - | 1.1 | 108 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 100 | 203,054 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 09 May 2024 | 100 | 66,997 | - | 15 | 1,500 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Apr 2024 | 5,017 | 60,648 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 6,349 | 203,154 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 5,017 | 45,156 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Apr 2024 | 6,349 | 66,997 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Mar 2024 | 6,348 | 55,631 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 6,348 | 209,503 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 5,017 | 50,173 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Mar 2024 | 5,017 | 49,283 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option | |
| Congleton Jon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 425,000 | 425,000 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Feb 2024 | 6,349 | 44,266 | - | 1.1 | 6,857 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 12 Feb 2024 | 5,017 | 37,917 | - | 0.5 | 2,709 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 6,349 | 215,851 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 5,017 | 55,190 | - | - | Stock Option | |
| Akkaraju Srinivas | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 12 Feb 2024 | 555,555 | 5,074,916 | - | 13.5 | 7,499,993 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Jan 2024 | 6,348 | 32,900 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 5,017 | 60,207 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 6,348 | 222,200 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Jan 2024 | 5,017 | 26,552 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Dec 2023 | 5,018 | 20,069 | - | 0.5 | 2,710 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 5,018 | 65,224 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.10 per share. | 17 Aug 2023 | 2,250 | 1,042,568 | - | 12.1 | 27,225 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.89 per share. | 11 Aug 2023 | 2,000 | 1,040,318 | - | 12.9 | 25,780 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 80,909 | 85,293 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 74,625 | 166,202 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 10 Aug 2023 | 76,182 | 0 | - | 12.8 | 975,891 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 10 Aug 2023 | 76,182 | 76,182 | - | 1.1 | 82,277 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 10 Aug 2023 | 80,909 | 0 | - | 12.8 | 1,036,444 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 10 Aug 2023 | 80,909 | 80,909 | - | 0.5 | 43,691 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.16 per share. | 10 Aug 2023 | 74,625 | 0 | - | 13.2 | 982,065 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 10 Aug 2023 | 74,625 | 74,625 | - | 0.5 | 40,298 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 76,182 | 228,548 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 88,000 | 88,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 44,000 | 0 | - | - | Stock Option | |
| Takeshi Takahashi | Director | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 44,000 | 0 | - | - | Stock Option | |
| Olivier Litzka | Director | Other type of transaction at price $ 0.00 per share. | 27 Apr 2023 | 44,000 | 0 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 99,800 | 99,800 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 1,446,357 | 0 | - | - | Series B Preferred Stock | ||
| Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 3,581,861 | 3,581,861 | - | - | Common Stock | ||
| Srinivas Akkaraju | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 937,500 | 4,519,361 | - | 16 | 15,000,000 | Common Stock |
| Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 2,135,504 | 0 | - | - | Series A Preferred Stock | ||
| Adam S. Levy | CFO, Chief Bus. Off. and Secy. | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 6,250 | 350,811 | - | 16 | 100,000 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 2,142,751 | 0 | - | - | Series B Preferred Stock | ||
| Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 4,314,093 | 8,944,579 | - | - | Common Stock | ||
| Brian Taylor Slingsby | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 250,000 | 9,194,579 | - | 16 | 4,000,000 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 2,171,342 | 0 | - | - | Series A Preferred Stock | ||
| Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 250,046 | 250,046 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 104,186 | 104,186 | - | - | Stock Option | |
| Adam S. Levy | CFO, Chief Bus. Off. and Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 97,518 | 97,518 | - | - | Stock Option | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Common Stock | |
| Alexander G. Asam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Olivier Litzka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Takeshi Takahashi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option |